CLINICAL_TRIALS
trial_result
· 2016-01-12
Clinical Trial Update: Study to Compare the Safety and Pharmacokinetics of CKD-397 [Phase 1]
Summary
Phase 1 study of CKD-397 evaluating safety and pharmacokinetics in Benign Prostatic Hyperplasia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Benign Prostatic Hyperplasia | Phase 1 | Status: COMPLETED